Opiate Receptors

Abstract

Morphine and its congeners are considered to be the best painkilling agents available. The molecular basis for the observed analgesics effects and other pharmacological functions of opioid analgesic drugs are defined by multiple opioid receptors. The opioid receptors are typical G protein‐coupled receptors and activate a variety of downstream signalling pathways via G protein‐ or β‐arrestin‐dependent pathway. Because of the existence of multiple endogenous peptide ligands and the crosstalk with other nonreceptor signalling pathways or neurological circuitries, the pharmacological functions mediated by the multiple opioid receptors are quite complex and are involved in multiple physiological processes, such as the effects on the functions of immune cells and neural stem cells.

Key Concepts

  • The molecular basis for the observed pharmacological functions of opioid analgesic drugs is defined by multiple opioid receptors.
  • Signalling transduction from opioid receptors is essential for the functions of opioids.
  • As classical GPCR, agonist‐selective signalling can be observed with opioid receptors.
  • Opioid analgesic drugs and opioid receptors contribute to other CNS functions in addition to pain relief.
  • The observed pharmacological functions of opioid analgesic drugs involve nonreceptor elements.

Keywords: morphine; pain; G protein‐coupled receptor; endogenous peptides; central nerve system

Figure 1. Serpentine representation of the deduced amino acid sequence of the μ‐, δ‐ and κ‐opioid receptors. The blue circles represent the amino acids that are common to all three types of opioid receptors. The green circles represent the amino acids that are common to two of the opioid receptors. The open circles represent the amino acids that are different in all three opioid receptors. The leaders indicate the N‐terminus and C‐termini of the receptors.
Figure 2. Schematic representation of mouse μ‐opioid receptor gene.
close

References

von Bohlen Und Halbach O (2007) Immunohistological markers for staging neurogenesis in adult hippocampus. Cell and Tissue Research 329 (3): 409–420.

Chang KJ and Cuatrecasas P (1979) Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. The Journal of Biological Chemistry 254 (8): 2610–2618.

Chang KJ, Cooper BR, Hazum E and Cuatrecasas P (1979) Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Molecular Pharmacology 16 (1): 91–104.

Chu J, Zheng H, Loh HH and Law PY (2008) Morphine‐induced mu‐opioid receptor rapid desensitization is independent of receptor phosphorylation and beta‐arrestins. Cellular Signalling 20 (9): 1616–1624.

Clark JA, Liu L, Price M, et al. (1989) Kappa opiate receptor multiplicity: evidence for two U50,488‐sensitive kappa 1 subtypes and a novel kappa 3 subtype. The Journal of Pharmacology and Experimental Therapeutics 251 (2): 461–468.

Duttaroy A and Yoburn BC (1995) The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82 (5): 1226–1236.

Eisch AJ, Barrot M, Schad CA, Self DW and Nestler EJ (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America 97 (13): 7579–7584.

Eisch AJ and Harburg GC (2006) Opiates, psychostimulants, and adult hippocampal neurogenesis: insights for addiction and stem cell biology. Hippocampus 16 (3): 271–286.

Evans CJ, Keith DE Jr, Morrison H, Magendzo K and Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258 (5090): 1952–1955.

Garbay‐Jaureguiberry C, Robichon A and Roques BP (1986) Synthesis and binding properties of specific photoaffinity ligands for mu and delta opioid receptor subtypes. International Journal of Peptide and Protein Research 27 (1): 34–43.

Gaudilliere B, Konishi Y, de la Iglesia N, Yao G and Bonni A (2004) A CaMKII‐NeuroD signaling pathway specifies dendritic morphogenesis. Neuron 41 (2): 229–241.

Gilbert PE and Martin WR (1976) The effects of morphine and nalorphine‐like drugs in the nondependent, morphine‐dependent and cyclazocine‐dependent chronic spinal dog. The Journal of Pharmacology and Experimental Therapeutics 198 (1): 66–82.

Goldstein A, Tachibana S, Lowney LI, Hunkapiller M and Hood L (1979) Dynorphin‐(1‐13), an extraordinarily potent opioid peptide. Proceedings of the National Academy of Sciences of the United States of America 76 (12): 6666–6670.

Granier S, Manglik A, Kruse AC, et al. (2012) Structure of the delta‐opioid receptor bound to naltrindole. Nature 485 (7398): 400–404.

Holmes MM and Galea LA (2002) Defensive behavior and hippocampal cell proliferation: differential modulation by naltrexone during stress. Behavioral Neuroscience 116 (1): 160–168.

Hughes J, Smith TW, Kosterlitz HW, et al. (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258 (5536): 577–580.

Hutchins AP, Yang Z, Li Y, et al. (2017) Models of global gene expression define major domains of cell type and tissue identity. Nucleic Acids Research 45 (5): 2354–2367.

Kenakin T (1995) Agonist‐receptor efficacy. I: mechanisms of efficacy and receptor promiscuity. Trends in Pharmacological Sciences 16 (6): 188–192.

Khurshid N, Hameed LS, Mohanasundaram S and Iyengar S (2010) Opioid modulation of cell proliferation in the ventricular zone of adult zebra finches (Taenopygia guttata). FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 24 (10): 3681–3695.

Kieffer BL, Befort K, Gaveriaux‐Ruff C and Hirth CG (1992) The delta‐opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proceedings of the National Academy of Sciences of the United States of America 89 (24): 12048–12052.

Koch T, Widera A, Bartzsch K, et al. (2005) Receptor endocytosis counteracts the development of opioid tolerance. Molecular Pharmacology 67 (1): 280–287.

Lasagna L (1964) The clinical evaluation of morphine and its substitutes as analgesics. Pharmacological Reviews 16: 47–83.

Law PY and Loh HH (1999) Regulation of opioid receptor activities. The Journal of Pharmacology and Experimental Therapeutics 289 (2): 607–624.

Lefkowitz RJ, Pitcher J, Krueger K and Daaka Y (1998) Mechanisms of β‐adrenergic receptor desensitization and resensitization. Advances in Pharmacology 42: 416–420.

Lefkowitz RJ and Whalen EJ (2004) Beta‐arrestins: traffic cops of cell signaling. Current Opinion in Cell Biology 16 (2): 162–168.

Leuner B, Gould E and Shors TJ (2006) Is there a link between adult neurogenesis and learning? Hippocampus 16 (3): 216–224.

Li CH and Chung D (1976) Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proceedings of the National Academy of Sciences of the United States of America 73 (4): 1145–1148.

Li W, He S, Zhou Y, et al. (2014) Neurod1 modulates opioid antinociceptive tolerance via two distinct mechanisms. Biological Psychiatry 76 (10): 775–784.

Lohse MJ, Benovic JL, Codina J, Caron MG and Lefkowitz RJ (1990) Beta‐Arrestin: a protein that regulates beta‐adrenergic receptor function. Science 248 (4962): 1547–1550.

Manglik A, Kruse AC, Kobilka TS, et al. (2012) Crystal structure of the μ‐opioid receptor bound to a morphinan antagonist. Nature 485 (7398): 321–326.

Martin WR, Eades CG, Thompson JA, Huppler RE and Gilbert PE (1976) The effects of morphine‐ and nalorphine‐ like drugs in the nondependent and morphine‐dependent chronic spinal dog. The Journal of Pharmacology and Experimental Therapeutics 197 (3): 517–532.

Paul D, Bodnar RJ, Gistrak MA and Pasternak GW (1989) Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. European Journal of Pharmacology 168 (3): 307–314.

Persson AI, Thorlin T, Bull C, et al. (2003) Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. The European Journal of Neuroscience 17 (6): 1159–1172.

Pert CB and Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179 (4077): 1011–1014.

Porreca F, Cowan A, Raffa RB and Tallarida RJ (1982) Tolerance and cross‐tolerance studies with morphine and ethylketocyclazocine. The Journal of Pharmacy and Pharmacology 34 (10): 666–667.

Rothman RB, France CP, Bykov V, et al. (1989) Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes. European Journal of Pharmacology 167 (3): 345–353.

Schulz R, Wuster M, Krenss H and Herz A (1980) Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285 (5762): 242–243.

Shenoy SK, Drake MT, Nelson CD, et al. (2006) beta‐arrestin‐dependent, G protein‐independent ERK1/2 activation by the beta2 adrenergic receptor. The Journal of Biological Chemistry 281 (2): 1261–1273.

Simon EJ, Hiller JM and Edelman I (1973) Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat‐brain homogenate. Proceedings of the National Academy of Sciences of the United States of America 70 (7): 1947–1949.

Terenius L (1973) Characteristics of the “receptor” for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacologica et Toxicologica 33 (5): 377–384.

Urban JD, Clarke WP, von Zastrow M, et al. (2007) Functional selectivity and classical concepts of quantitative pharmacology. The Journal of Pharmacology and Experimental Therapeutics 320 (1): 1–13.

Wilden U, Wust E, Weyand I and Kuhn H (1986) Rapid affinity purification of retinal arrestin (48 kDa protein) via its light‐dependent binding to phosphorylated rhodopsin. FEBS Letters 207 (2): 292–295.

Winocur G, Wojtowicz JM, Sekeres M, Snyder JS and Wang S (2006) Inhibition of neurogenesis interferes with hippocampus‐dependent memory function. Hippocampus 16 (3): 296–304.

Wu H, Wacker D, Mileni M, et al. (2012) Structure of the human kappa‐opioid receptor in complex with JDTic. Nature 485 (7398): 327–332.

Xu H, Ni Q, Jacobson AE, Rice KC and Rothman RB (1991) Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes. Life Sciences 49 (18): PL141–PL146.

Zajac JM and Roques BP (1985) Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides. Journal of Neurochemistry 44 (5): 1605–1614.

Zhang Y, Loh HH and Law PY (2016) Effect of opioid on adult hippocampal neurogenesis. The Scientific World Journal 2016: 2601264.

Zheng H, Chu J, Qiu Y, Loh HH and Law PY (2008a) Agonist‐selective signaling is determined by the receptor location within the membrane domains. Proceedings of the National Academy of Sciences of the United States of America 105 (27): 9421–9426.

Zheng H, Loh HH and Law PY (2008b) β‐Arrestin‐dependent μ‐opioid receptor‐activated extracellular signal‐regulated kinases (ERKs) translocate to nucleus in contrast to G protein‐dependent ERK activation. Molecular Pharmacology 73 (1): 178–190.

Zheng H, Loh HH and Law PY (2010a) Agonist‐selective signaling of G protein‐coupled receptor: mechanisms and implications. IUBMB Life 62 (2): 112–119.

Zheng H, Zeng Y, Chu J, et al. (2010b) Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. Journal of Neuroscience 30 (24): 8102–8110.

Zheng H, Zeng Y, Zhang X, et al. (2010c) μ‐opioid receptor agonists differentially regulate the expression of miR‐190 and NeuroD. Molecular Pharmacology 77 (1): 102–109.

Zheng H, Zhang Y, Li W, Loh HH and Law PY (2013) NeuroD modulates opioid agonist‐selective regulation of adult neurogenesis and contextual memory extinction. Neuropsychopharmacology 38 (5): 770–777.

Zuo Z (2005) The role of opioid receptor internalization and beta‐arrestins in the development of opioid tolerance. Anesthesia & Analgesia 101 (3): 728–734.

Further Reading

Law PY, Wong YH and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annual Review of Pharmacology and Toxicology 40: 389–430.

Mansour A, Fox CA, Akil H and Watson SJ (1995) Opioid‐receptor mRNA expression in rat CNS: anatomical and functional implications. Trends in Neuroscience 18: 22–29.

Minami M and Satoh M (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neuroscience Research 23: 121–145.

North RA (1986) Opioid receptor types and membrane ion channels. Trends in Neuroscience 9: 114–117.

Pasternak GW (1988) Multiple morphine and enkephalin receptors and the relief of pain. Journal of American Medical Association 259: 1362–1367.

Reisine T and Pasternak G (1996) Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG (eds) The Pharmacological Basis of Therapeutics, 9th edn, pp 521–555. McGraw Hill: New York.

Simon EJ and Gioannini TL (1993) Opioid receptor multiplicity: isolation, purification and chemical characterization of binding sites. In: Herz A (ed.) Opioid I, Handbook of Experimental Pharmacology, vol. 104, pp 3–26. Springer: Berlin.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Zheng, Hui, Law, Ping‐Yee, and Loh, Horace H(Feb 2020) Opiate Receptors. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000290.pub2]